台股 » 個股 » 東生華 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

東生華

(8432)
可現股當沖
  • 股價
    62.7
  • 漲跌
    ▼0.9
  • 漲幅
    -1.42%
  • 成交量
    94
  • 產業
    上櫃 生技醫療類股
  • 36人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
東生華 (8432)籌碼相關-元大-南勢角 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-南勢角 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/13262.8000.0062.7021411.42%
2024/12/09163.1000.0062.8011420.70%
2024/12/06163.7000.0063.9011410.71%
2024/12/0400.00165.0065.10-1143-0.70%
2024/11/14161.9000.0061.2011380.72%
2024/07/29264.05266.6066.6002190.00%
2024/07/02169.80169.3069.2002260.00%
2024/06/25270.60268.8068.3002270.00%
2024/05/1500.00165.7065.20-1321-0.31%
2024/05/14166.0000.0065.6013230.31%
2024/05/0900.00167.3067.10-1313-0.32%
2024/05/08365.33265.9064.4012990.33%
2024/05/07263.90262.6062.3002840.00%
2024/01/1100.000.452.8753.10-0.4427-0.09%
2024/01/0500.001.150.7151.10-1.1416-0.25%
2024/01/0400.000.150.7050.60-0.1418-0.01%
2023/12/2900.000.150.3050.30-0.1416-0.02%
2023/12/26252.00250.7050.4004110.00%
2023/12/19148.9500.0048.8013980.25%
2023/12/150.148.9400.0048.850.13970.02%
2023/12/140.149.4900.0048.550.13950.02%
2023/12/13049.6000.0049.1003930.01%
2023/11/27252.30252.8051.2003720.00%
2023/11/15150.30150.9050.1003390.00%
2023/11/130.150.2000.0050.300.13270.03%
2023/11/100.152.7000.0052.500.13180.03%
2023/11/080.256.6300.0056.400.22780.07%
2023/11/07558.64559.0657.9002560.00%
2023/11/06354.70355.1054.8002090.00%
2023/11/03251.60352.8352.00-1173-0.58%
2023/11/02152.5000.0051.0011160.86%
2023/10/30348.82349.5548.700540.00%
2023/09/0800.00146.2046.35-177-1.28%
2023/09/06146.3500.0046.401781.27%
2023/07/2400.00347.3047.00-372-4.16%
2022/09/3000.00243.0543.60-2304-0.66%
2022/09/07248.7000.0048.8022720.73%
2022/07/2900.00346.4344.95-3130-2.30%
2022/03/07142.6500.0042.501442.23%
2021/10/26146.0000.0046.351831.19%
2021/10/25147.0500.0047.501801.24%
2021/08/20139.9000.0039.7011140.87%
2021/06/0100.00343.3043.30-3190-1.58%
2021/05/2500.00241.9041.90-2179-1.12%
2021/05/11142.8500.0042.2011280.78%
2021/05/07144.0500.0044.0011240.80%
2021/05/05546.0000.0045.4551184.21%
2020/12/1100.00158.7058.70-158-1.72%
2020/11/2500.00160.0060.00-153-1.88%
2020/11/20160.0000.0060.301541.83%
2020/11/1800.00161.7061.00-153-1.88%
2020/11/05161.8000.0062.201482.05%
2020/07/09172.0000.0071.901991.01%
2019/10/3000.00179.8079.40-136-2.78%
2019/10/29179.1000.0079.901362.77%
2019/03/2800.00270.1069.70-262-3.21%
2019/02/13267.2000.0067.602474.25%
2018/06/0700.00172.8072.00-1420-0.24%
2018/05/29169.3000.0069.1014230.24%
2018/02/0200.00175.4074.80-1122-0.82%
東生華液態切片技術新突破 成功識別92%肺癌基因突變Anue鉅亨-2024/08/26
東生華攜手陽明交大簽署MOU 聚焦人才培育、精準藥物開發Anue鉅亨-2024/07/22
東生華法說會/併購高峰、三大業務加持 今年營收拚增五成達12億UDN聯合新聞網-2024/03/25
東生華 相關文章